asa glp 1 agonist guidelines How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like The 2023 ASA position on

It contains three amino acids (glutamine, cysteine, and glycine) and is critical in protecting cells from oxidative stress and neutralizing free radicals

Regular review and adjustment of therapy is essential to maintain optimal diabetes control whilst minimising adverse effects

Aftercare: Refrain from engaging in intense physical activity for Activity Restrictions: 48 hours following the treatment, as perspiration can lead to the expulsion of the solution from the skin, thereby diminishing the efficacy of the treatment

However, at higher concentrations (10 mg/dl), uric acid promotes cellular senescence and downregulates EGF/EGFR signaling